SCIENTISTS have found a pill that offers ‘100 per cent protection’ against Ebola – sparking hopes of eradicating the deadly ...
New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...
As well as protecting the monkeys from death, the treatment also evoked an immune response. Senior author Dr Thomas Geisbert ...
Monkeys infected with Ebola can be cured with a pill, according to a new study out Friday that could pave the way for more ...
The vaccine is designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above. It will be used to support preventive vaccination in countries most ...
Scientists have found that an oral antiviral drug successfully prevents monkeys from dying after an Ebola infection, an advance that may prevent future outbreaks of the deadly virus. At such a ...
Scientists at Cornell University have developed a new type of vaccine that may provide stronger and longer-lasting protection ...
The United Nations has launched an emergency appeal to raise $11.2 million to help fund Uganda's response to an Ebola outbreak that has killed two people, after the country's health budget was ...
The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.
A vaccine was only widely approved in 2019, and while two intravenous antibody treatments improve outcomes, they require costly cold storage.